Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Global HealthBOM:543654 -0.04%96 Days Payable is 75.13 as of Jun. 2026, which is 18% below its 10-year median of 91.68. GuruFocus rates BOM:543654 with a GF Score™ of 96/100 and a GF Value™ of ₹1,562.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 612 Healthcare Providers & Services companies, Global Health ranks better than 63.24% on this metric.
The historical rank and industry rank for Global Health's Days Payable or its related term are showing as below:
BOM:543654'
s Days Payable Range Over the Past 10 Years
Min: 79.17 Med: 91.68 Max: 146.91
Current: 79.55
During the past 7 years, Global Health's highest Days Payable was 146.91. The lowest was 79.17. And the median was 91.68.
BOM:543654's Days Payable is ranked better than 63.24% of 612
companies
in the Healthcare Providers & Services industry
Industry Median: 56.91
vs BOM:543654: 79.55
Global Health's Days Payable
increased
from Jun. 2025 (74.36) to Jun. 2026 (75.13).
It may suggest that Global Healthdelayed paying its suppliers.
The historical data trend for Global Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543654 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Global Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Global Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Global Health's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Health (BOM:543654) has a Days Payable of 75.13 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Global Health and its competitors. This is 18% below median its historical median of 91.68. Over the past decade, Global Health's Days Payable has ranged from 79.17 to 146.91. According to the industry distribution chart, Global Health ranks #225 out of 612 companies in the Healthcare Providers & Services industry, placing it in the top 36.8%.
Is Global Health's Days Payable too high?
Global Health's current Days Payable of 75.13 is 18% below median its 10-year median of 91.68. Over the past 10 years, this metric has ranged from a low of 79.17 to a high of 146.91. The Healthcare Providers & Services industry median Days Payable is 56.91. Global Health's value of 75.13 is 32% above this industry median. Based on the distribution chart, Global Health ranks #225 out of 612 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Global Health has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Global Health's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #225 out of 612 companies for Days Payable. This puts Global Health in the upper half of its industry. The industry median Days Payable is 56.91. Global Health's value of 75.13 is 32% above this benchmark. Historically, Global Health's own Days Payable has ranged from 79.17 to 146.91 over the past decade. While the company's 10-year median is 91.68 vs. the industry median of 56.91, Global Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.91, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Health's current Days Payable of 75.13 is 32% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Global Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Health's current Days Payable is 75.13, which is 18% below median its own 10-year median of 91.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,562.98, compared to a current price of ₹1,404.70 — trading 10.1% below its estimated fair value. The current Days Payable is 75.13, which is 18% below median its 10-year median of 91.68 and 32% above the Healthcare Providers & Services industry median of 56.91. Global Health's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Global Health (BOM:543654), the current Days Payable is 75.13 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Health (BOM:543654) Overvalued in 2026?
Based on GuruFocus' analysis, Global Health stock appears to be undervalued.
The current stock price of ₹1,404.70 is trading 10.1% below its estimated GF Value™ of ₹1,562.98.
GuruFocus considers Global Health to be Modestly Undervalued.
Key valuation signals for BOM:543654:
Days Payable: 75.13 (18% below median its 10-year median of 91.68)
GF Value™: ₹1,562.98 vs. price of ₹1,404.70 (10.1% below fair value)
Industry Position: 32% above the Healthcare Providers & Services median (#225 of 612)
No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
96GF Score
Get the complete analysis for BOM:543654
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543654 has been successfully added to your 
